About us

SyndicateNL, a Dutch company, was founded in 2020 and is headquartered in Wageningen University and Research Center in the Netherlands. The company focuses on the research, development and production of pharmaceuticals, health products, medical beauty, cosmetics, cancer research and genetically controlled plant products. The company carries out the introduction and breeding of seed sources, and the cultivation, production and processing of industrial hemp raw materials in legal areas around the world. Currently, we are actively expanding international market channels and developing international supply chains of industrial hemp raw materials and sales of industrial hemp branded consumer packaged goods and retail experience products in Asia, Africa, Europe and the Americas. At the same time, the company is actively participating in international institutional cooperation and conducting clinical research on industrial hemp extract medical products.

Nordic ÖU Syndicatenl Cannabidiol Pharmaceutical company, was founded in 2024 and headquartered in Tallinn, the capital of Estonia, the Nordic European company, the company focuses on the global market commercialization of small molecule biopharmaceutical research and development based on cannabidiol CBD ingredients, medical beauty product development, health care product research and development.

 

Syndicate NL B.V., Han Investment B.V., M&Z Europe B.V. Founder & CTO
Possesses extensive professional experience in the extraction technology and process development of active pharmaceutical ingredients; holds multiple patents in the field of food processing, with rich experience in food carrier technology, drug sustained-release technology, and the development of drug delivery technologies based on natural plant extracts (such as cannabidiol); has facilitated several collaborative projects between leading enterprises in Europe and China, as well as key universities; currently dedicated to project development and technology transfer in the fields of health and sustainable development; has conducted in-depth research in the field of plant-based foods and holds invention patents related to plant-based foods; has published in top journals regarding in-depth environmental cost and economic benefit analyses of various processing technologies.
 
ÖU Syndicatenl Cannabidiol Pharmaceutical Founder & CEO
Syndicate NL B.V Co-Founder & CEO
Focus on the global market commercialization of small molecule biopharmaceutical research and development based on cannabidiol CBD ingredients, medical product and cosmetic plastic surgery product development, health product research and development, and other commercialization of  related products and R&D.

Get in touch with us to explore our latest products and services.